$371.31
▼ -0.2% Today
as of Jul 22, 16:49 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 24
▼ 1
Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
Analyst Report: HCA Healthcare, Inc.
Overview
52-week range
$330
$557
18% of range
Avg surprise (last 2)
+11.1%
Avg reaction (last 2)
-3.0%
0% positive
Latest IV / EM
42%
EM ±9.6% · $370 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $7.15 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $6.96 | — | — | — | — | financials |
| Fri Jul 25, 2025 | Jun/2025 | $6.84 | $6.19 | +10.5% | — | -2.1% | earnings |
| Fri Apr 25, 2025 | Mar/2025 | $6.45 | $5.77 | +11.8% | — | -4.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $4.88 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $5.53 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $5.93 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $3.91 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $4.29 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Jul 24, 2026 | Jun/2026 | BMO | $7.57 | $6.84 | +10.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.11B | — | $19.16B | $18.61B | $18.32B | — | $17.49B | $17.49B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $1.62B | — | $1.64B | $1.65B | $1.61B | — | $1.27B | $1.46B |
| EPS (diluted) | $7.15 | — | $6.96 | $6.83 | $6.45 | — | $4.88 | $5.53 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M |
| Inventory | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B |
| Total current assets | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B |
| Total assets | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B |
| Long-term debt | $39.49B | $41.60B | $38.40B | $39.38B | $41.06B | $38.33B | $38.28B | $36.31B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B |